Potential immune­related adverse events during dabrafenib and trametinib treatment: A case series of patients with BRAF V600E melanoma.

Potential immunerelated adverse events during dabrafenib and trametinib treatment: A case series of patients with BRAF V600E melanoma.

Morgese, Francesca; Cognigni, Valeria; Scortichini, Laura; Ranallo, Nicoletta; Lunerti, Valentina; Migliore, Antonella; Tronconi, Francesca; Berardi, Rossana.

Afiliação

Morgese F; Oncology Clinic, Polytechnic University of Marche, United Hospitals of Ancona, I-60126 Ancona, Italy.
Cognigni V; Oncology Clinic, Polytechnic University of Marche, United Hospitals of Ancona, I-60126 Ancona, Italy.
Scortichini L; Oncology Clinic, Polytechnic University of Marche, United Hospitals of Ancona, I-60126 Ancona, Italy.
Ranallo N; Oncology Unit, Macerata Hospital, I-62100 Macerata, Italy.
Lunerti V; Osteoncology and Rare Tumors Center, IRCCS Romagna Scientific Institute for Cancer Research and Care 'Dino Amadori', I-47014 Meldola, Italy.
Migliore A; Oncology Clinic, Polytechnic University of Marche, United Hospitals of Ancona, I-60126 Ancona, Italy.
Tronconi F; Oncology Clinic, Polytechnic University of Marche, United Hospitals of Ancona, I-60126 Ancona, Italy.
Berardi R; Oncology Clinic, Polytechnic University of Marche, United Hospitals of Ancona, I-60126 Ancona, Italy.

Mol Clin Oncol ; 18(1): 2, 2023 Jan.

Article em En | MEDLINE | ID: mdl-36545211